Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis Ltd in Gynecological Endocrinology
- Vol. 3 (1), 71-94
- https://doi.org/10.3109/09513598909152454
Abstract
This paper summarizes what has been learned over the years about the role of eicosanoids in the pathogenesis of primary dysmenorrhea, endometriosis and menstrual migraine. The role of prostaglandins (PGs) in the pathogenesis of primary dysmenorrhea is inferred from four main observations: firstly, the clinical symptoms of primary dysmenorrhea are similar to those induced by the administration of PGF2α and PGE2 for the induction of labour; secondly, the increased production of PGs by the endometrium during the luteal and menstrual phases of ovulatory cycles is consistent with the occurrence of primary dysmenorrhea mainly in ovulatory cycles; thirdly, the concentrations of PGF2α and PGE2 in the endometrium and menstrual fluid of dysmenorrheic women are significantly higher than in controls; fourthly, certain PG inhibitors have been proved to be effective in the treatment of dysmenorrhea. The change in PG production can explain the major symptoms of primary dysmenorrhea, including the increased uterine contractility, uterine ischemia and the lowering of the pain threshold to chemical and physical stimuli in the pelvic nerve terminals. Moreover, recent experimental data suggest that leukotrienes (LTs) might be among the alternative pathogenetic causes of primary dysmenorrhea. The data which support a relationship between eicosanoids and endometriosis are as follows: endometriotic tissue produces PGs; the peritoneal fluid concentration of PGF2α increases significantly after the induction of endometriosis in laboratory animals; the concentration of PGs in peritoneal fluid of some patients with endometriosis is greater than in controls and, finally, the number and activation of pelvic macrophages which are able to synthesize eicosanoids increase in patients with endometriosis. Possible roles for eicosanoids in the pathogenesis of infertility and secondary dysmenorrhea induced by endometriosis have been suggested. Eicosanoids are probably also involved in the pathogenesis of menstrual migraine. Different types of PGs might play a role both in the initial vasoconstriction during the prodromal phase of migraine and in the vasodilation and sensitization to pain typical of the pain phase.Keywords
This publication has 66 references indexed in Scilit:
- DysmenorrhoeaBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Alterations in Intrauterine Pressure, Menstrual Fluid Prostaglandin F Levels, and Pain in Dysmenorrheic Women Treated With NimesulideThe Journal of Clinical Pharmacology, 1987
- A Comparative Crossover Study of Piroxicam vs. Mefenamic Acid and Diclofenac in FranceActa Obstetricia et Gynecologica Scandinavica, 1986
- Worldwide Studies Comparing Piroxicam and NaproxenActa Obstetricia et Gynecologica Scandinavica, 1986
- Contentsintroductioncurrent Concepts in the Etiology and Treatment of Primary DysmenorrheaActa Obstetricia et Gynecologica Scandinavica, 1986
- Stimulus-dependent inhibition of superoxide generation by prostaglandinsClinical Immunology and Immunopathology, 1985
- Vasopressin and Prostaglandins in Premenstrual Pain and Primary DysmenorrheaActa Obstetricia et Gynecologica Scandinavica, 1984
- Prostaglandins and EndometriosisActa Obstetricia et Gynecologica Scandinavica, 1983
- Dysmenorrhoea and ProstaglandinsDrugs, 1981
- ORIGIN OF PERITONEAL FLUID IN WOMEN: AN OVARIAN EXUDATION PRODUCTBJOG: An International Journal of Obstetrics and Gynaecology, 1980